Objectives:
The purpose of this study was to evaluate practice patterns in antenatal sonographic assessment of congenital diaphragmatic hernia (CDH) through surveys and interviews conducted within the North American Fetal Therapy Network (NAFTNet). Methods: All NAFTNet centres were invited to participate in this study, which was conceived as part of a NAFTNet fetal endoscopic tracheal occlusion (FETO) consortium initiative aimed at standardising antenatal prognostication of CDH. Participants completed a 14-question survey and were interviewed and observed during acquisition of lung-to-head ratio (LHR) on de-identified sonographic CDH images. Results: Participants included 49 physicians: 19 from 9 NAFTNet FETO consortium centres and 30 from 18 NAFTNet centres outside the FETO consortium. Study participants included 39 maternal-fetal medicine specialists, 9 radiologists and 1 pediatric surgeon. All participants completed surveys and 31 were interviewed. All centres obtained an observed-to-expected (o/e) LHR or LHR as part of CDH prognostication. Most participants felt confident in obtaining o/e LHR or LHR and felt it was at least moderately relevant for prognostication. Image selection criteria for lung area assessment was consistent including an axial chest view, 4-chamber view of the heart with clear lung borders without shadowing. Most non-FETO centres preferred the longest diameter method. Most FETO consortium participants preferred the trace method, but also used the longest diameter in practice. Centres varied in number of o/e LHRs obtained, gestational age at assessment and calculator used for o/e LHR. Conclusions: Standardisation of antenatal prognostication of CDH is essential to provide accurate parental counselling, identify appropriate candidates for fetal intervention and evaluate neonatal outcomes across centres. Variability in o/e LHR measurement practices were identified across NAFTNet, which should be standardised to ensure consistent antenatal CDH prognostication assessments among centres. Objectives: To determine the differences in perinatal outcomes between echogenic intra-abdominal structures (EIAS) and echogenic bowel (EB). Methods: This is a retrospective cohort study of 128 patients who were diagnosed with EIAS during anatomical survey ultrasound at a high-volume maternal fetal medicine referral centre between January 2015-December 2017. EIAS was defined as any echogenic structure in the fetal abdomen >1 mm and was evaluated based on location. Primary outcomes included rates of intrauterine demise, pregnancy termination, genetic anomalies and other major fetal anomalies. Secondary outcomes were NICU admission and rate of preterm birth. Fisher's exact test was used where appropriate. Results: There were 128 patients with EIAS. The organ distribution of EIAS findings were as follows: 68 (53%) bowel, 19 (15%) kidney, 11 (8%) liver, 10 (8%) stomach, 10 (8%) spleen, 10 (8%) non-specified, 1 (0.7%) ovary, and 2 (1.5%) gallbladder. The median gestational age at diagnosis on ultrasound of EB vs EIAS was 20.1 weeks vs. 20.6 weeks. The groups were similar in median age (34 vs. 35 years) and median BMI (26 vs. 27.4 kg/m 2 ). Median GA at delivery was 39.3 vs. 41.4 weeks. There were no statistical differences for both primary and secondary outcomes for EIAS of all organs compared to EB. However, of all the organs, echogenic kidney was associated with an increased risk for termination or intrauterine demise over EB (36.8% vs. 11.8%; p=0.017). Kidney EIAS was associated with an increased risk of NICU admission (41.6% vs. 8.3%; p=0.0342), but not of preterm birth. Conclusions: Pregnancies with echogenic bowel and echogenic intra-abdominal structures resulted in had similar pregnancies and neonatal outcomes. Echogenic kidney, however, is associated with increased risk of adverse antenatal and postnatal outcomes. This information should be incorporated into counseling when EIAS are noted on fetal imaging. Objectives: Correct prediction allows proper treatments. The predictive capacity has been questioned and it needed to be proven in different geographic setting, with different population and care. The objective was to evaluate lung volume with O/E LHR in Chile, double check with Leuven and report survival. Methods: Prospective evaluation of all CDH cases, since 2009. All measures were obtained by single observer (MY) and checked by the medical team from Leuven, in order to assured the image quality, and therefore, validate the method.
